BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6341482)

  • 1. Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence.
    Weintraub A; Lindberg AA; Kasper DL
    J Infect Dis; 1983 Apr; 147(4):780. PubMed ID: 6341482
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunochemical investigations of six Bacteroides serotypes.
    Meisel-Mikołajczyk F; Gałkowska H
    Acta Microbiol Pol; 1976; 25(4):389-99. PubMed ID: 65113
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of the antigenic structure of the Bacteroides fragilis species.
    Romond C; Beerens H
    Infection; 1980; 8 Suppl 2():S142. PubMed ID: 7005093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of heat-labile antigen(s) of Bacteroides fragilis associated with non-homogeneous immunofluorescent staining.
    Schwan A; Danielsson D; Forsum U
    Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):13-9. PubMed ID: 6177189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of Bacteroides fragilis O antigens.
    Hofstad T
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):9-13. PubMed ID: 65902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
    Kasper DL; Onderdonk AB; Reinap BG; Linberg AA
    J Infect Dis; 1980 Nov; 142(5):750-6. PubMed ID: 7462689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Bacteroides fragilis by indirect immunofluorescence.
    Weintraub A; Lindberg AA; Nord CE
    Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical and biological studies of antigens isolated from a strain of Bacteroides fragilis.
    Meisel-Mikołajczyk F; Rokosz A; Sawicka-Grzelak A; Zuijderduijn J; Beckmann I; Paelinck J
    J Appl Bacteriol; 1984 Dec; 57(3):405-11. PubMed ID: 6530379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides.
    Weintraub A; Larsson BE; Lindberg AA
    Infect Immun; 1985 Jul; 49(1):197-201. PubMed ID: 4008048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
    Reid JH; Patrick S; Tabaqchali S
    J Gen Microbiol; 1987 Jan; 133(1):171-9. PubMed ID: 3309142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Bacteroides ovatus in clinical specimens by immunofluorescence with a monoclonal antibody to B. fragilis lipopolysaccharide.
    Viljanen MK; Linko L; Lehtonen OP
    J Clin Microbiol; 1988 Mar; 26(3):448-52. PubMed ID: 3281973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteroides fragilis lipopolysaccharide and group B streptococcus serotype II glycocalyx have a common major antigenic determinant.
    Linko L; Viljanen MK
    APMIS; 1988 Sep; 96(9):805-12. PubMed ID: 2458746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the antigenic composition of the fragilis group of Bacteroides.
    Elhag KM; Alkarmi TO
    J Med Microbiol; 1991 Aug; 35(2):118-22. PubMed ID: 1875392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative serology of two clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Landay ME; Baldwin W
    J Clin Microbiol; 1979 May; 9(5):643-4. PubMed ID: 90054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
    Kasper DL; Onderdonk AB; Bartlett JG
    J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.